Uploaded April 2026 | Updated September 2026, 1 week ago

---

NEJM Clinician Editor-in-Chief Raja-Elie Abdulnour, MD, explains a trial investigating the efficacy and safety of psilocybin as a therapy for treatment-resistant depression. Read the key results and comment from Peter Roy-Byrne, MD clinician.nejm.org.